The online version of this article (doi:10.1186/s12890-017-0397-3) contains supplementary material, which is available to authorized users.
Epigenetic variations in peripheral blood have potential as biomarkers for disease. This systematic review assesses the association of lung function and chronic obstructive pulmonary disease (COPD) with DNA methylation profiles in peripheral blood from population-based studies.
Online databases Medline, Embase, and Web of Science were searched. Google Scholar was searched to identify grey literature. After removing duplicate articles, 1155 articles were independently screened by two investigators. Peer reviewed reports on population-based studies that examined peripheral blood DNA methylation in participants with measured lung function (FEV1, FEV1/FVC ratio) or known COPD status were selected for full-text review. Six articles were suitable for inclusion. Information regarding study characteristics, designs, methodologies and conclusions was extracted. A narrative synthesis was performed based on published results.
Three of the six articles assessed the association of COPD with DNA methylation, and two of these also included associations with lung function. Overall, five reports examined the association of lung function with DNA methylation profiles. Five of the six articles reported ‘significant’ results. However, no consistent CpG sites were identified across studies for COPD status or lung function values.
DNA methylation patterns in peripheral blood from individuals with reduced lung function or COPD may be different to those in people with normal lung function. However, this systematic review did not find any consistent associations of lung function or COPD with differentially methylated CpG sites. Large studies with a longitudinal design to address reverse causality may prove a more fruitful area of research.
PROSPERO 2016: CRD42016037352.
Additional file 1: Tables S1. Search terms (n = 92) used within MEDLINE, EMBASE and Web of Science. (DOCX 13 kb)12890_2017_397_MOESM1_ESM.docx
Additional file 2: Tables S2. First 25 exclusion categorisations for both investigators. This process was repeated for all 1155 articles undergoing Title and Abstract screening. (DOCX 17 kb)12890_2017_397_MOESM2_ESM.docx
Bird AP. CpG-rich islands and the function of DNA methylation. Nature. 1985;321:209–13. CrossRef
Kotaniemi JT, Sovijärvi A, Lundbäck B. Chronic obstructive pulmonary disease in Finland: Prevalence and risk factors, COPD: J Chron Obstruct Pulmon Dis. 2005;2:331–9.
Zhang Y, Yang R, Burwinkel B, Breitling LP, Brenner H. F2RL3 methylation as a biomarker of current and lifetime smoking exposures. Environ Health Perspect. 2014;122:131. PubMed
Deary IJ, Gow AJ, Pattie A, Starr JM. Cohort profile: the Lothian Birth Cohorts of 1921 and 1936. Int J Epidemiol. 1921;2012(41):1576–84.
Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ, O’Donnell WJ, Reilly JJ, Ginns L, Mentzer S, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med. 1998;157:1770–8. CrossRefPubMed
- Systematic review of lung function and COPD with peripheral blood DNA methylation in population based studies
André F. S. Amaral
Faisal I. Rezwan
Ian M. Adcock
John W. Holloway
Deborah L. Jarvis
on behalf of the ALEC study
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II